澳大利亚和新西兰血液透析撤除的双国家注册研究
结果显示透析撤除死亡率从1997-2000年的1.02/100患者年(占全因死亡11%)升至2013-16年的2.20/100患者年(占32%),独立预测因素包括高龄、女性、白人种族、合并症及较近年代开始透析。
要点
- 透析撤除死亡率随时间显著上升,2013-16年达2.20/100患者年,占全因死亡32%。
- 高龄(≥70岁)、女性、白人种族及合并症与透析撤除风险升高独立相关。
- 较近年代(2013-16)开始透析者撤除风险是1997-2000年的3.96倍。
核心结论
- 在澳大利亚和新西兰接受慢性血液透析的ESKD患者中,因撤除透析而死亡的比例随时间逐渐增加。
- 透析撤除的独立预测因素包括高龄、女性、白人种族、合并症及较近年代开始透析。
研究设计与样本
- 采用竞争风险回归模型分析透析撤除死亡的预测因素,以非撤除原因死亡作为竞争风险事件。
主要发现
- 透析撤除死亡率从1997-2000年的1.02/100患者年(占全部死亡的11%)上升至2013-16年的2.20/100患者年(占32%),P < 0.001。
- 与60-70岁参考组相比,≥70岁患者撤除透析的亚分布风险比(SHR)为1.77(95% CI 1.66-1.89)。
- 女性SHR 1.14(95% CI 1.09-1.21);白人参考下,亚洲人SHR 0.56(95% CI 0.49-0.65),原住民和托雷斯海峡岛民SHR 0.83(95% CI 0.74-0.93),太平洋岛民SHR 0.47(95% CI 0.39-0.68)。
- 合并冠心病SHR 1.18(95% CI 1.11-1.25),脑血管病SHR 1.15(95% CI 1.08-1.23),慢性肺病SHR 1.13(95% CI 1.06-1.21)。
- 与1997-2000年参考组相比,2013-16年开始透析者撤除风险SHR 3.96(95% CI 3.56-4.48)。
临床怎么用
- 临床中应关注高龄、女性、白人种族及合并心脑血管或慢性肺病的血液透析患者,及时识别透析撤除意愿。
- 透析撤除死亡占比显著增加,提示肾内科团队需加强姑息治疗和共同决策沟通。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Withdrawal from dialysis is an increasingly common cause of death in patients with end-stage kidney disease (ESKD). As most published reports of dialysis withdrawal have been outside the Oceania region, the aims of this study were to determine the frequency, temporal pattern and predictors of dialysis withdrawal in Australian and New Zealand patients receiving chronic haemodialysis. METHODS: This study included all people with ESKD in Australia and New Zealand who commenced chronic haemodialysis between 1 January 1997 and 31 December 2016, using data from the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry. Competing risk regression models were used to identify predictors of dialysis withdrawal mortality, using non-withdrawal cause of death as the competing risk event. RESULTS: Among 40 447 people receiving chronic haemodialysis (median age 62 years, 61% male, 9% Indigenous), dialysis withdrawal mortality rates increased from 1.02 per 100 patient-years (11% of all deaths) during the period 1997-2000 to 2.20 per 100 patient-years (32% of all deaths) during 2013-16 (P < 0.001). Variables that were significantly associated with a higher likelihood of haemodialysis withdrawal were older age {≥70 years subdistribution hazard ratio [SHR] 1.77 [95% confidence interval (CI) 1.66-1.89]; reference 60-70 years}, female sex [SHR 1.14 (95% CI 1.09-1.21)], white race [Asian SHR 0.56 (95% CI 0.49-0.65), Aboriginal and Torres Strait Islander SHR 0.83 (95% CI 0.74-0.93), Pacific Islander SHR 0.47 (95% CI 0.39-0.68), reference white race], coronary artery disease [SHR 1.18 (95% CI 1.11-1.25)], cerebrovascular disease [SHR 1.15 (95% CI 1.08-1.23)], chronic lung disease [SHR 1.13 (95% CI 1.06-1.21)] and more recent era [2013-16 SHR 3.96 (95% CI 3.56-4.48); reference 1997-2000]. CONCLUSIONS: Death due to haemodialysis withdrawal has become increasingly common in Australia and New Zealand over time. Predictors of haemodialysis withdrawal include older age, female sex, white race and haemodialysis commencement in a more recent era.
引用
- Chan S, Marshall MR, Ellis RJ, et al. Haemodialysis withdrawal in Australia and New Zealand: a binational registry study. Nephrol Dial Transplant. 2020. PMID: 31397483. doi:10.1093/ndt/gfz160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。